Airway diseases
Respiratory critical care
Respiratory infections
PG13 Postgraduate course
Using biomarkers in clinical practice in airway disease: asthma and COPD
Clinical
Aims : To assess the roles of biomarkers in airway diseases (COPD and asthma), especially biomarkers in induced sputum and blood eosinophils, exhaled nitric oxide and airway hyper-responsiveness; to determine the relationships of biomarkers with risk stratification and identification of responders to treatment; and to determine the associations of biomarkers with clinical phenotypes, disease monitoring and the development of new drugs.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Paediatrician, Respiratory critical care physician, Journalist
Methods :
Epidemiology, General respiratory patient care, Pulmonary function testing
14:00
Airway hyperresponsiveness in asthma and COPD
R. Louis(Liège, Belgium)
COI
-
Description
1
14:30
Exhaled nitric oxide in asthma and COPD
S. Loukides(Athens, Greece)
COI
-
Description
2
15:00
Induced sputum in asthma and COPD
A. Spanevello(Milano, Italy)
COI
3
16:00
Blood eosinophils in asthma and COPD
M. Bafadhel(London, United Kingdom)
COI
5
16:30
Group assignment
R. Louis(Liège, Belgium)
COI
S. Loukides(Athens, Greece)
COI
A. Spanevello(Milano, Italy)
COI
M. Bafadhel(London, United Kingdom)
COI
6
. . .
